In parallel, the COVID-19 Δ cohort displayed a declining impact on major organs, reflected by the fact that most biochemical biomarkers showed lessened values when compared to those in the influenza cohort, such as ALT, AST, BUN, CK-MB, and LDH, showing the diminished viremia of the delta variant SARS-CoV-2. This evidence concerns the gene GPT and COVID-19.